ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,484,641 | -9.2% | 202,087 | +2.8% | 0.02% | 0.0% |
Q2 2023 | $6,043,515 | -14.7% | 196,601 | 0.0% | 0.02% | -20.0% |
Q1 2023 | $7,083,534 | -8.8% | 196,601 | 0.0% | 0.02% | -13.8% |
Q4 2022 | $7,769,672 | -1.6% | 196,601 | 0.0% | 0.03% | -9.4% |
Q3 2022 | $7,899,000 | -6.8% | 196,601 | -2.4% | 0.03% | 0.0% |
Q2 2022 | $8,472,000 | +7.9% | 201,517 | 0.0% | 0.03% | +28.0% |
Q1 2022 | $7,851,000 | -2.2% | 201,517 | 0.0% | 0.02% | +8.7% |
Q4 2021 | $8,030,000 | +113.5% | 201,517 | +93.6% | 0.02% | +91.7% |
Q3 2021 | $3,762,000 | -9.0% | 104,106 | +3.2% | 0.01% | -14.3% |
Q2 2021 | $4,135,000 | – | 100,869 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
Brown University | 621,759 | $24,777,000 | 6.04% |
Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |